Status:
COMPLETED
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
Lead Sponsor:
Robin, Alan L., M.D.
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical oc...
Detailed Description
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical oc...
Eligibility Criteria
Inclusion
- Currently using one or two topical ocular hypotensive medications
Exclusion
- Hypersensitivity to any component of medication
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00329095
Start Date
December 1 2005
End Date
April 1 2006
Last Update
May 24 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.